Skip to content

Remote Endarterectomy vs Remote Endarterectomy + Drug Coated Balloon (DCB) Angioplasty in Patients With the Femoral Artery Occlusive Disease

Remote Endarterectomy vs Remote Endarterectomy Supplement DCB Balloon Angioplasty in Patients With the Femoral Artery Occlusive Disease (TASCII D)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03142347
Enrollment
50
Registered
2017-05-05
Start date
2017-01-31
Completion date
2019-01-31
Last updated
2017-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoral Artery Occlusion

Keywords

remote endarterectomy, DCB balloon

Brief summary

Comparison effectiveness two methods revascularization of the superficial femoral artery: remote endarterectomy vs. remote endarterectomy supplemented DCB angioplasty in patients with steno-occlusive lesion of the femoro-popliteal segment of TASCII D

Detailed description

Given that more and more devices appear to deliver cytotoxic drugs into the depth of atherosclerotic plaque, it is interesting to study the effect of these drugs when applied directly after plaque removal.

Interventions

PROCEDURERemote endarterectomy

Performed open endarterectomy of the common, deep, initial of superficial femoral artery. Proximal plaque exfoliate as far as possible in the superficial femoral artery. After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque. Plastic of arteriotomy wounds performed patches of xenopericardium. Control patency of the arterial vessel is performed intraoperatively by X-ray angiography. When rendering residual stenosis or intimal dissection, limiting blood flow, complemented by endovascular intervention plasticity.

PROCEDURERemote endarterectomy + DCB balloon

Performed open endarterectomy of the common, deep, initial of superficial femoral artery. Proximal plaque exfoliate as far as possible in the superficial femoral artery. After that, the translational and rotational motions loops under fluoroscopic guidance, continuing detachment of plaque in the antegrade direction to the distal end of plaque. Plastic of arteriotomy wounds performed patches of xenopericardium. And balloon angioplasty of superficial femoral artery with DCB balloon is perform. Control patency of the arterial vessel is performed intraoperatively by X-ray angiography. When rendering residual stenosis or intimal dissection, limiting blood flow, complemented by endovascular intervention plasticity.

Sponsors

Meshalkin Research Institute of Pathology of Circulation
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
45 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Patients with occlusive lesions of C and D type femoral artery and with chronic lower limb ischemia (II-IV degree by Fontaine, 4-6 degree by Rutherford) * Patients who consented to participate in this study.

Exclusion criteria

* Chronic heart failure of III-IV functional class by New York Heart Association (NYHA) classification. * Decompensated chronic pulmonary heart * Severe hepatic or renal failure (bilirubin\> 35 mmol / l, glomerular filtration rate \<60 mL / min); * Polyvalent drug allergy * Cancer in the terminal stage with a life expectancy less than 6 months; * Acute ischemic * Expressed aortic calcification tolerant to remote endarterectomy * Patient refusal to participate or continue to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
the change of lumen in target vesselBaseline, 3 days after the operation, 6 month, 12 month, 2 yearsstenosis or occlusions

Secondary

MeasureTime frameDescription
Vessel wall thickness3 days after the operation, 6 month, 12 month, 2 yearsmm
Number of participants with limb salvage3 days after the operation, 6 month, 12 month, 2 years
Number of participants with complications in long-term period after the operation.3 days after the operation, 6 month, 12 month, 2 years

Countries

Russia

Contacts

Primary ContactArtem Rabtsun
a_rabtsun@meshalkin.ru+79137078354

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026